Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma
S. A. M. van de Schans, A. N. M. Wymenga, D. J. van Spronsen, H. C. Schouten, J. W. W. Coebergh, M. L. G. Janssen-Heijnen*
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma'. Together they form a unique fingerprint.